| Product Code: ETC7912775 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to import a significant amount of hemostatic agents, with top supplying countries being Estonia, China, Sweden, Germany, and the Netherlands. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. Despite a modest compound annual growth rate (CAGR) of 1.62% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -8.63%. This suggests a potential shift in market dynamics or external factors impacting the importation of hemostatic agents in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Hemostatic Agents Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Hemostatic Agents Market - Industry Life Cycle |
3.4 Latvia Hemostatic Agents Market - Porter's Five Forces |
3.5 Latvia Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Latvia Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in Latvia |
4.2.2 Rising incidence of road accidents and trauma cases |
4.2.3 Growing awareness about hemostatic agents among healthcare professionals in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hemostatic agents |
4.3.2 Limited availability of advanced hemostatic products in the Latvian market |
5 Latvia Hemostatic Agents Market Trends |
6 Latvia Hemostatic Agents Market, By Types |
6.1 Latvia Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Latvia Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Latvia Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Latvia Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Latvia Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Latvia Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Latvia Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Latvia Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Latvia Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Latvia Hemostatic Agents Market Export to Major Countries |
7.2 Latvia Hemostatic Agents Market Imports from Major Countries |
8 Latvia Hemostatic Agents Market Key Performance Indicators |
8.1 Number of surgical procedures using hemostatic agents |
8.2 Adoption rate of new hemostatic technologies in hospitals |
8.3 Rate of complications or adverse events associated with hemostatic agents |
9 Latvia Hemostatic Agents Market - Opportunity Assessment |
9.1 Latvia Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Latvia Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Hemostatic Agents Market - Competitive Landscape |
10.1 Latvia Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Latvia Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here